In October, Pfizer (NYSE:PFE) signaled its plans to raise its COVID-19 vaccine price to roughly $110 to $130 per dose. The new price would go effect after the U.S. government’s purchase program for the vaccine expires, said Angela Lukin, Pfizer’s global primary care and U.S. president. Senator Warren and Senator-elect Welch asked Pfizer CEO Albert…
Pfizer mulls boosting COVID-19 vaccine price to $110 or more per dose
Pfizer (NYSE:PFE) signaled its intent to increase its COVID-19 vaccine price to roughly $110 to $130 per dose after the U.S. government’s purchase program for the vaccine expires, according to Angela Lukin, Pfizer’s global primary care and U.S. president. The COVID-19 vaccine price hike would pertain to patients 12 and older. The company could revise…